Fusion Pharmaceuticals to be acquired by AstraZeneca
Canadian Manufacturing
MARCH 19, 2024
HAMILTON and BOSTON — Fusion Pharmaceuticals Inc., Fusion Pharmaceuticals says that RCs have emerged as a promising modality in cancer treatment over recent years. .” Deepening our collaboration with AstraZeneca presents an exciting opportunity for the Fusion team.”
Let's personalize your content